Home/Filings/4/0001415889-24-030057
4//SEC Filing

Rochlin Kate 4

Accession 0001415889-24-030057

CIK 0001740279other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:15 PM ET

Size

5.6 KB

Accession

0001415889-24-030057

Insider Transaction Report

Form 4
Period: 2024-12-19
Rochlin Kate
Chief Operating Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-12-19+302,839302,839 total
    Exercise: $0.24Exp: 2034-12-19Common Stock (302,839 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001898521

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:15 PM ET
Size
5.6 KB